IL130067A0 - 2-Imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists - Google Patents

2-Imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists

Info

Publication number
IL130067A0
IL130067A0 IL13006797A IL13006797A IL130067A0 IL 130067 A0 IL130067 A0 IL 130067A0 IL 13006797 A IL13006797 A IL 13006797A IL 13006797 A IL13006797 A IL 13006797A IL 130067 A0 IL130067 A0 IL 130067A0
Authority
IL
Israel
Prior art keywords
imidazolinylaminoindazole
alpha
compounds useful
adrenoceptor agonists
adrenoceptor
Prior art date
Application number
IL13006797A
Other languages
English (en)
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of IL130067A0 publication Critical patent/IL130067A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Resins (AREA)
IL13006797A 1996-11-25 1997-11-21 2-Imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists IL130067A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3174096P 1996-11-25 1996-11-25
PCT/US1997/020551 WO1998023609A1 (en) 1996-11-25 1997-11-21 2-imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists

Publications (1)

Publication Number Publication Date
IL130067A0 true IL130067A0 (en) 2000-02-29

Family

ID=21861136

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13006797A IL130067A0 (en) 1996-11-25 1997-11-21 2-Imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists

Country Status (20)

Country Link
EP (1) EP0944620A1 (tr)
JP (1) JP2001506599A (tr)
KR (1) KR20000069104A (tr)
CN (1) CN1244864A (tr)
AR (1) AR010643A1 (tr)
AU (1) AU5433998A (tr)
BR (1) BR9713535A (tr)
CA (1) CA2272644A1 (tr)
CO (1) CO4910166A1 (tr)
CZ (1) CZ183999A3 (tr)
HU (1) HUP9904660A3 (tr)
ID (1) ID22676A (tr)
IL (1) IL130067A0 (tr)
NO (1) NO992502L (tr)
NZ (1) NZ335882A (tr)
PE (1) PE47099A1 (tr)
SK (1) SK69699A3 (tr)
TR (1) TR199901542T2 (tr)
WO (1) WO1998023609A1 (tr)
ZA (1) ZA9710576B (tr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9908175D0 (en) * 1999-04-09 1999-06-02 Lilly Co Eli Method of treating neurological disorders
US6433186B1 (en) 2000-08-16 2002-08-13 Astrazeneca Ab Amidino derivatives and their use as thormbin inhibitors
US20100311965A1 (en) 2007-12-28 2010-12-09 Carna Biosciences Inc. 2-aminoquinazoline derivative
WO2010074753A1 (en) 2008-12-23 2010-07-01 Map Pharmaceuticals, Inc. Inhalation devices and related methods for administration of sedative hypnotic compounds
CN112538074A (zh) * 2020-12-24 2021-03-23 艾希尔（深圳）药物研发有限公司 一种溴莫尼定脱溴杂质的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH641782A5 (en) * 1978-12-07 1984-03-15 Siegfried Ag 1H- and 2H-indazole derivatives
US4526898A (en) * 1980-09-05 1985-07-02 Siegfried Aktiengesselschaft Antihypertensive 4-(2-imidazolin-2-yl-amino)-2-methyl-indazole
PT735877E (pt) * 1993-12-17 2000-12-29 Procter & Gamble Compostos de 6-(2-imidazolinilamino)quinoxalina uteis como agonistas do receptor alfa-2 adrenergico
US5478858A (en) * 1993-12-17 1995-12-26 The Procter & Gamble Company 5-(2-imidazolinylamino) benzimidazole compounds useful as alpha-2 adrenoceptor agonists

Also Published As

Publication number Publication date
ID22676A (id) 1999-12-09
SK69699A3 (en) 2000-06-12
WO1998023609A1 (en) 1998-06-04
KR20000069104A (ko) 2000-11-25
CO4910166A1 (es) 2000-04-24
HUP9904660A3 (en) 2002-02-28
HUP9904660A2 (hu) 2000-06-28
NO992502D0 (no) 1999-05-25
NZ335882A (en) 2000-12-22
AU5433998A (en) 1998-06-22
EP0944620A1 (en) 1999-09-29
ZA9710576B (en) 1998-09-16
PE47099A1 (es) 1999-06-12
TR199901542T2 (tr) 2000-01-21
AR010643A1 (es) 2000-06-28
CN1244864A (zh) 2000-02-16
NO992502L (no) 1999-07-26
JP2001506599A (ja) 2001-05-22
CA2272644A1 (en) 1998-06-04
CZ183999A3 (cs) 1999-11-17
BR9713535A (pt) 2000-03-21

Similar Documents

Publication Publication Date Title
HUP9904215A3 (en) 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists
AP9801356A0 (en) Prostaglandin agonists
IL129423A0 (en) Improved preparation for use as contrast agent
HRP20010089B1 (en) 2-substituted-1-piperidyl benzimidazole compounds as orl1-receptor agonists
IL146578A0 (en) Beta 2 adrenoceptor agonists
IL130077A0 (en) Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists
PL336348A1 (en) Indazolamide compounds as serotoninergic agents
HUP0002966A3 (en) 2-imidazolinylaminobenzoxazole compounds useful as alpha-2 adrenoceptor agonists
IL130067A0 (en) 2-Imidazolinylaminoindazole compounds useful as alpha-2 adrenoceptor agonists
IL120320A0 (en) Microbicidal composition
PL319904A1 (en) Nitrobenzamides useful as antiarrythimic agents
ZA9710574B (en) 2-imidazolinylaminobenzothiazole compounds useful as alpha-2 adrenoceptor agonists.
IL130023A0 (en) Guanidinylamino heterocycle compounds useful as alpha-2 adrenoceptor agonists
IL132384A0 (en) 5-(2-Imidazolinylamino) benzimidazole compounds useful as alpha - 2 adrenoceptor agonists
GB9601356D0 (en) Novel compound
AP9901651A0 (en) Nitro-benzamide useful as anti-arrhytmic agent
AU3640795A (en) Penetrating protectant
AU1345900A (en) Oxazolidinones useful as alpha 1a adrenoceptor antagonists
GB9600894D0 (en) Novel compound
GB9600886D0 (en) Novel compound
AU1346000A (en) Oxazolidinones useful as alpha 1a adrenoceptor antagonists
AU1345800A (en) Oxazolidinones useful as alpha 1a adrenoceptor antagonists
GB9720305D0 (en) Compound
TW361550U (en) Improved structure for the piston
GB9407574D0 (en) Compound